Learn more

SHANGHAI BENEMAE PHARMACEUTICAL CORP

Overview
  • Total Patents
    39
  • GoodIP Patent Rank
    56,881
  • Filing trend
    ⇩ 42.0%
About

SHANGHAI BENEMAE PHARMACEUTICAL CORP has a total of 39 patent applications. It decreased the IP activity by 42.0%. Its first patent ever was published in 2002. It filed its patents most often in Australia, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are NORDIC NANOVECTOR ASA, ADC THERAPEUTICS S RL and IMUNAMI LABORATORIES PTE LTD.

Patent filings per year

Chart showing SHANGHAI BENEMAE PHARMACEUTICAL CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zuo Yajun 17
#2 Yu Gang 14
#3 Liu Xiaowu 9
#4 Yu Quan 9
#5 Wang Wenyi 9
#6 Qian Lifen 7
#7 Wang Shichuang 7
#8 Xia Jing 7
#9 Yu Zhiwen 7
#10 Xiong Chunlin 6

Latest patents

Publication Filing date Title
US2020024362A1 Anti-coagulation factor xi antibody
AU2018436195A1 Anti-factor XI antibodies
CN110237239A For treating the GLP-1 composition of fat and Weight management
MX2019009500A Anti-coagulation factor xi antibody.
AU2002313869B2 A method of producing glucagon-like peptide 1(GLP-1)7-36 and an GLP-1 analogue
AU2002257498B2 A frog skin antibacterial peptide derivative